Altium Capital Management LP Galera Therapeutics, Inc. Transaction History

Altium Capital Management LP

  • $177 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.27 - $8.28 $381,768 - $2.49 Million
-300,605 Closed
0 $0
Q3 2021

Nov 17, 2021
BUY
$7.04 - $10.49 $2.12 Million - $3.15 Million
300,605 New
300,605 $2.44 Million
Q3 2021

Nov 15, 2021
SELL
$7.04 - $10.49 $1.55 Million - $2.31 Million
-219,900 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$6.08 - $10.44 $1.34 Million - $2.3 Million
219,900 New
219,900 $2.16 Million

Others Institutions Holding GRTX

# of Institutions
38
Shares Held
10.7M
Call Options Held
10.3K
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $3.76M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email